2026 Q3 Portfolio Activity
In 2026 Q3, Privium Fund Management B.V. maintained a portfolio of 70 distinct positions. The most significant new addition was NEBIUS GROUP N.V., now representing 1.83% of the total fund value. They heavily accumulated shares in SPACE EXPLORATION TECHN CORP, increasing the position by 525.0%. Conversely, Privium Fund Management B.V. completely exited their position in AST SPACEMOBILE INC.
Position History
hover any row below to update
Loading…
Total Positions
70
Quarter
2026 Q3
Top Holding
TSLA (15.5%)
Top 10 Concentration
66.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 70
Privium Fund Management B.V. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSLA
TESLA INC
|
Consumer Cyclical | 15.49% | 17.62% |
#1
Prev: #1
|
6.5 |
—
|
-3,000 | -1.3% |
P
S
|
225,000 | $79,832,250 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
SHOP
SHOPIFY INC
|
Technology | 8.77% | 7.76% |
#2
Prev: #2
|
5.5 |
—
|
-65,000 | -17.6% |
P
S
|
305,000 | $45,231,500 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
AMD
ADVANCED MICRO ...
|
Technology | 7.36% | 6.62% |
#3
Prev: #3
|
4.9 |
—
|
no change | no change |
P
S
|
62,000 | $37,929,120 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
SPCX
SPACE EXPLORATI...
|
ETF | 7.32% | 1.26% |
#4
18
Prev: #22
|
6.4 |
—
|
210,000 | 525.0% |
P
S
|
250,000 | $37,715,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
PLTR
PALANTIR TECHNO...
|
Technology | 7.26% | 4.29% |
#5
2
Prev: #7
|
4.4 |
—
|
no change | no change |
P
S
|
200,000 | $37,410,000 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
AMZN
AMAZON COM INC
|
Consumer Cyclical | 6.77% | 6.13% |
#6
2
Prev: #4
|
3.7 |
—
|
no change | no change |
P
S
|
140,000 | $34,881,000 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
CBRS
CEREBRAS SYSTEM...
|
Technology | 3.82% | 2.46% |
#7
7
Prev: #14
|
4.5 |
—
|
50,500 | 83.5% |
P
S
|
111,000 | $19,719,150 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
NVDA
NVIDIA CORPORAT...
|
Technology | 3.59% | 2.98% |
#8
3
Prev: #11
|
2.4 |
—
|
no change | no change |
P
S
|
81,000 | $18,498,780 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
SPOT
SPOTIFY TECHNOL...
|
Communication Services | 3.12% | 4.64% |
#9
3
Prev: #6
|
1.2 |
—
|
-22,000 | -40.0% |
P
S
|
33,000 | $16,083,540 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 3.02% | 4.66% |
#10
5
Prev: #5
|
3.2 |
—
|
29,079 | 9.1% |
P
S
|
349,003 | $15,582,984 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
IREN
IREN LIMITED
|
Financial Services | 2.94% | 2.86% |
#11
1
Prev: #12
|
3.2 |
—
|
30,000 | 8.8% |
P
S
|
370,150 | $15,131,732 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 2.74% | 3.51% |
#12
4
Prev: #8
|
1.6 |
—
|
-18,404 | -7.9% |
P
S
|
215,818 | $14,125,288 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
LMND
LEMONADE INC
|
Financial Services | 2.37% | 3.23% |
#13
3
Prev: #10
|
1.9 |
—
|
no change | no change |
P
S
|
270,259 | $12,199,491 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
OPEN
OPENDOOR TECHNO...
|
Real Estate | 2.36% | 3.35% |
#14
5
Prev: #9
|
3.4 |
—
|
1,200,000 | 30.4% |
P
S
|
5,140,904 | $12,183,942 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 2.12% | 1.92% |
#15
3
Prev: #18
|
1.8 |
—
|
no change | no change |
P
S
|
48,400 | $10,932,592 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
NBIS
NEBIUS GROUP N....
|
Communication Services | 1.83% | — |
#16
Prev: #—
|
4.2 |
—
|
40,000 | — |
NEW
|
40,000 | $9,435,200 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
PRQR
PROQR THRAPEUTI...
|
Healthcare | 1.76% | 1.89% |
#17
2
Prev: #19
|
1.2 |
—
|
-52,875 | -1.0% |
P
S
|
5,467,149 | $9,075,467 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 1.71% | 1.92% |
#18
1
Prev: #17
|
1.2 |
—
|
-66,174 | -16.6% |
P
S
|
333,193 | $8,806,291 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.54% | 1.80% |
#19
1
Prev: #20
|
2.6 |
—
|
3,000 | 7.5% |
P
S
|
42,944 | $7,918,444 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.14% | — |
#20
Prev: #—
|
4.0 |
—
|
89,151 | — |
NEW
|
89,151 | $5,866,136 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
QURE
UNIQURE NV
|
Healthcare | 1.01% | 2.78% |
#21
8
Prev: #13
|
0.4 |
—
|
-112,125 | -34.2% |
P
S
|
216,197 | $5,223,319 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.99% | 0.63% |
#22
5
Prev: #27
|
3.4 |
—
|
9,235 | 81.2% |
P
S
|
20,607 | $5,084,571 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 0.92% | 1.09% |
#23
Prev: #23
|
1.4 |
—
|
no change | no change |
P
S
|
229,857 | $4,751,144 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.87% | 0.79% |
#24
1
Prev: #25
|
1.3 |
—
|
no change | no change |
P
S
|
75,000 | $4,500,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 0.85% | 1.42% |
#25
4
Prev: #21
|
0.3 |
—
|
-102,085 | -48.6% |
P
S
|
107,915 | $4,384,586 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.72% | — |
#26
Prev: #—
|
3.8 |
—
|
26,200 | — |
NEW
|
26,200 | $3,716,208 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.68% | 2.08% |
#27
11
Prev: #16
|
0.3 |
—
|
-105,763 | -31.2% |
P
S
|
233,037 | $3,502,546 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.64% | 0.76% |
#28
2
Prev: #26
|
0.8 |
—
|
-1,200 | -10.7% |
P
S
|
9,970 | $3,315,623 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
BNTX
BIONTECH SE
|
Healthcare | 0.61% | 0.51% |
#29
Prev: #29
|
2.2 |
—
|
2,000 | 6.6% |
P
S
|
32,100 | $3,155,430 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 0.59% | 0.45% |
#30
3
Prev: #33
|
2.7 |
—
|
30,105 | 22.1% |
P
S
|
166,605 | $3,035,543 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
ABEV
AMBEV SA
|
Consumer Defensive | 0.56% | 0.46% |
#31
1
Prev: #32
|
2.7 |
—
|
187,556 | 23.4% |
P
S
|
989,723 | $2,889,991 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
CRSP
CRISPR THERAPEU...
|
Healthcare | 0.53% | 0.45% |
#32
2
Prev: #34
|
2.2 |
—
|
4,000 | 8.9% |
P
S
|
48,974 | $2,709,242 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 0.44% | 0.49% |
#33
2
Prev: #31
|
2.2 |
—
|
12,400 | 6.3% |
P
S
|
208,512 | $2,293,632 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 0.43% | 0.44% |
#34
1
Prev: #35
|
2.7 |
—
|
21,000 | 29.9% |
P
S
|
91,282 | $2,231,845 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
ZTS
ZOETIS INC
|
Healthcare | 0.32% | 0.23% |
#35
7
Prev: #42
|
2.6 |
—
|
6,321 | 36.5% |
P
S
|
23,643 | $1,650,991 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
BTG
B2GOLD CORP
|
Basic Materials | 0.27% | 0.13% |
#36
12
Prev: #48
|
2.6 |
—
|
70,422 | 36.1% |
P
S
|
265,505 | $1,385,936 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 0.25% | 0.22% |
#37
6
Prev: #43
|
1.1 |
—
|
no change | no change |
P
S
|
90,110 | $1,289,474 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.22% | 0.25% |
#38
3
Prev: #41
|
2.1 |
—
|
34,000 | 17.1% |
P
S
|
232,900 | $1,134,223 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
RNAC
CARTESIAN THERA...
|
Healthcare | 0.22% | 0.29% |
#39
1
Prev: #38
|
0.6 |
—
|
3,325 | 2.2% |
P
S
|
155,000 | $1,117,550 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 0.19% | 0.21% |
#40
4
Prev: #44
|
1.1 |
—
|
no change | no change |
P
S
|
414,311 | $981,917 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 0.18% | 0.11% |
#41
13
Prev: #54
|
2.6 |
—
|
106,060 | 29.2% |
P
S
|
469,490 | $910,811 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
RIG
TRANSOCEAN LTD
|
Energy | 0.16% | 0.13% |
#42
9
Prev: #51
|
2.1 |
—
|
10,095 | 6.9% |
P
S
|
155,699 | $815,863 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
MOH
MOLINA HEALTHCA...
|
Healthcare | 0.15% | 0.13% |
#43
9
Prev: #52
|
2.6 |
—
|
1,085 | 36.4% |
P
S
|
4,064 | $768,502 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
LULU
LULULEMON ATHLE...
|
Consumer Cyclical | 0.13% | 0.11% |
#44
12
Prev: #56
|
2.6 |
—
|
1,960 | 38.7% |
P
S
|
7,023 | $675,542 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
RCKT
ROCKET PHARMACE...
|
Healthcare | 0.12% | 0.15% |
#45
1
Prev: #46
|
1.0 |
—
|
no change | no change |
P
S
|
244,146 | $642,104 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
NOV
NOV INC
|
Energy | 0.12% | 0.14% |
#46
1
Prev: #47
|
0.5 |
—
|
-7,976 | -19.0% |
P
S
|
34,050 | $637,757 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 0.10% | 0.13% |
#47
3
Prev: #50
|
1.0 |
—
|
no change | no change |
P
S
|
155,000 | $523,900 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
SD
SANDRIDGE ENERG...
|
Energy | 0.10% | 0.10% |
#48
9
Prev: #57
|
1.0 |
—
|
no change | no change |
P
S
|
38,792 | $523,304 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
NU
NU HLDGS LTD
|
Financial Services | 0.09% | 0.11% |
#49
4
Prev: #53
|
0.5 |
—
|
-5,832 | -13.3% |
P
S
|
38,168 | $483,207 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-03 | |||
|
SA
SEABRIDGE GOLD ...
|
Basic Materials | 0.08% | 0.08% |
#50
8
Prev: #58
|
0.5 |
—
|
-2,340 | -14.2% |
P
S
|
14,172 | $401,634 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-03 |
Showing 1-50 of 70 holdings